• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过对具有淋巴结靶向能力的聚合物杂化胶束进行修饰来提高癌症疫苗的效力。

Tailoring polymeric hybrid micelles with lymph node targeting ability to improve the potency of cancer vaccines.

机构信息

Key Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu No. 17 Section, 3 Renmin South Rd, Chengdu, 610041, PR China.

Key Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu No. 17 Section, 3 Renmin South Rd, Chengdu, 610041, PR China.

出版信息

Biomaterials. 2017 Apr;122:105-113. doi: 10.1016/j.biomaterials.2017.01.010. Epub 2017 Jan 11.

DOI:10.1016/j.biomaterials.2017.01.010
PMID:28110170
Abstract

It has been widely accepted that lymph nodes (LNs) are critical targets of cancer vaccines and particles sized between 10 and 100 nm with a neutral or negative surface charge are preferred for lymphatic transfer after subcutaneous or intradermal injection. However their limited uptake by antigen presenting cells (APCs) and inadequate retention within LNs undoubtedly restrains their strength on activating T cell immunity. Here, we address this issue by tailoring the physicochemical properties of polymeric hybrid micelles (HMs), which are self-assembled from two amphiphilic diblock copolymers, poly-(ethylene glycol) phosphorethanolamine (PEG-PE) and polyethylenimine-stearic acid conjugate (PSA) via hydrophobic and electrostatic interactions. We successfully encapsulate melanoma antigen peptide Trp2 and Toll-like receptor-9 (TLR-9) agonist CpG ODN into HMs with a size of sub-30 nm. Their surface characteristics which are found closely related to their in vivo kinetics can be modulated by simply adjusting the molar ratio of PEG-PE and PSA. Our results demonstrated the optimized HMs with an equal mol of PEG-PE and PSA can potently target proximal LNs where their cargos are efficiently internalized by DCs. Furthermore, HMs mediated Trp2/CpG delivery system greatly expands antigen specific cytotoxic T lymphocytes (CTLs) and offers a strong anti-tumor effect in a lung metastatic melanoma model.

摘要

人们普遍认为淋巴结(LNs)是癌症疫苗的关键靶点,并且粒径在 10 至 100nm 之间、表面带中性或负电荷的颗粒,经皮下或皮内注射后更有利于淋巴转移。然而,它们被抗原提呈细胞(APCs)摄取的能力有限,并且在 LNs 中的保留不足,这无疑限制了它们在激活 T 细胞免疫方面的效力。在这里,我们通过调整聚合物混合胶束(HM)的物理化学性质来解决这个问题,HM 是通过疏水和静电相互作用自两种两亲性嵌段共聚物聚(乙二醇)磷乙醇胺(PEG-PE)和聚乙二胺-硬脂酸缀合物(PSA)组装而成的。我们成功地将黑色素瘤抗原肽 Trp2 和 Toll 样受体-9(TLR-9)激动剂 CpG ODN 包封到尺寸小于 30nm 的 HM 中。它们的表面特性与体内动力学密切相关,可以通过简单地调整 PEG-PE 和 PSA 的摩尔比来调节。我们的结果表明,具有等摩尔 PEG-PE 和 PSA 的优化 HM 可以有效地靶向近端 LNs,其中其货物被 DC 有效内化。此外,HM 介导的 Trp2/CpG 递药系统大大扩增了抗原特异性细胞毒性 T 淋巴细胞(CTL),并在肺转移黑色素瘤模型中提供了强大的抗肿瘤作用。

相似文献

1
Tailoring polymeric hybrid micelles with lymph node targeting ability to improve the potency of cancer vaccines.通过对具有淋巴结靶向能力的聚合物杂化胶束进行修饰来提高癌症疫苗的效力。
Biomaterials. 2017 Apr;122:105-113. doi: 10.1016/j.biomaterials.2017.01.010. Epub 2017 Jan 11.
2
Rational design of Polymeric Hybrid Micelles to Overcome Lymphatic and Intracellular Delivery Barriers in Cancer Immunotherapy.用于克服癌症免疫治疗中淋巴和细胞内递送障碍的聚合物杂化胶束的合理设计
Theranostics. 2017 Sep 26;7(18):4383-4398. doi: 10.7150/thno.20745. eCollection 2017.
3
Cationic micelle delivery of Trp2 peptide for efficient lymphatic draining and enhanced cytotoxic T-lymphocyte responses.三肽 Trp2 的阳离子胶束递呈促进高效淋巴引流和增强细胞毒性 T 淋巴细胞应答。
J Control Release. 2015 Feb 28;200:1-12. doi: 10.1016/j.jconrel.2014.12.024. Epub 2014 Dec 23.
4
Synthetic Polymeric Mixed Micelles Targeting Lymph Nodes Trigger Enhanced Cellular and Humoral Immune Responses.合成聚合物混合胶束靶向淋巴结引发增强的细胞和体液免疫应答。
ACS Appl Mater Interfaces. 2018 Jan 24;10(3):2874-2889. doi: 10.1021/acsami.7b14004. Epub 2018 Jan 10.
5
Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis.载色氨酸 2 肽和 CpG 佐剂的多功能纳米粒诱导针对黑色素瘤及其肺转移的强烈细胞毒性 T 淋巴细胞反应。
J Control Release. 2013 Nov 28;172(1):259-265. doi: 10.1016/j.jconrel.2013.08.021. Epub 2013 Sep 1.
6
Microdosed Lipid-Coated (67)Ga-Magnetite Enhances Antigen-Specific Immunity by Image Tracked Delivery of Antigen and CpG to Lymph Nodes.微剂量包被(67)Ga-磁铁矿通过对淋巴结进行图像跟踪递呈抗原和 CpG,增强了抗原特异性免疫。
ACS Nano. 2016 Jan 26;10(1):1602-18. doi: 10.1021/acsnano.5b07253. Epub 2016 Jan 5.
7
Antigen-loaded polymeric hybrid micelles elicit strong mucosal and systemic immune responses after intranasal administration.抗原负载的聚合物杂化胶束经鼻腔给药后可引发强烈的黏膜和全身免疫应答。
J Control Release. 2017 Sep 28;262:151-158. doi: 10.1016/j.jconrel.2017.07.034. Epub 2017 Jul 26.
8
Nanovaccine loaded with poly I:C and STAT3 siRNA robustly elicits anti-tumor immune responses through modulating tumor-associated dendritic cells in vivo.纳米疫苗负载聚肌苷酸:胞苷酸和 STAT3 siRNA 通过体内调节肿瘤相关树突状细胞强烈引发抗肿瘤免疫反应。
Biomaterials. 2015 Jan;38:50-60. doi: 10.1016/j.biomaterials.2014.10.050. Epub 2014 Nov 12.
9
Enhanced Cancer Vaccination by In Situ Nanomicelle-Generating Dissolving Microneedles.原位生成胶束溶解微针增强癌症疫苗接种。
ACS Nano. 2018 Oct 23;12(10):9702-9713. doi: 10.1021/acsnano.8b04146. Epub 2018 Sep 4.
10
Lymph Node Delivery Strategy Enables the Activation of Cytotoxic T Lymphocytes and Natural Killer Cells to Augment Cancer Immunotherapy.淋巴结投递策略可激活细胞毒性 T 淋巴细胞和自然杀伤细胞,增强癌症免疫治疗。
ACS Appl Mater Interfaces. 2021 May 19;13(19):22213-22224. doi: 10.1021/acsami.1c03709. Epub 2021 May 6.

引用本文的文献

1
Lipid nanoparticles: a promising tool for nucleic acid delivery in cancer immunotherapy.脂质纳米颗粒:癌症免疫治疗中核酸递送的一种有前景的工具。
Med Oncol. 2025 Aug 6;42(9):409. doi: 10.1007/s12032-025-02939-3.
2
Functional Nucleic-Acid-Decorated Spherical Nanoparticles: Preparation Strategies and Current Applications in Cancer Therapy.功能核酸修饰的球形纳米颗粒:制备策略及其在癌症治疗中的当前应用
Small Sci. 2021 Feb 9;1(3):2000056. doi: 10.1002/smsc.202000056. eCollection 2021 Mar.
3
Iontophoresis-Driven Microneedle Arrays Delivering Transgenic Outer Membrane Vesicles in Program that Stimulates Transcutaneous Vaccination for Cancer Immunotherapy.
离子电渗驱动的微针阵列以刺激经皮癌症免疫治疗疫苗接种的程序递送转基因外膜囊泡。
Small Sci. 2023 Oct 2;3(11):2300126. doi: 10.1002/smsc.202300126. eCollection 2023 Nov.
4
Cancer Nanovaccines: Mechanisms, Design Principles, and Clinical Translation.癌症纳米疫苗:作用机制、设计原则及临床转化
ACS Nano. 2025 May 6;19(17):16204-16223. doi: 10.1021/acsnano.4c15765. Epub 2025 Apr 9.
5
-Glucan-modified nanoparticles with different particle sizes exhibit different lymphatic targeting efficiencies and adjuvant effects.具有不同粒径的葡聚糖修饰纳米颗粒表现出不同的淋巴靶向效率和佐剂效应。
J Pharm Anal. 2024 Dec;14(12):100953. doi: 10.1016/j.jpha.2024.02.007. Epub 2024 Feb 23.
6
Nano-fluorescence imaging: advancing lymphatic disease diagnosis and monitoring.纳米荧光成像:推动淋巴疾病的诊断与监测
Nano Converg. 2024 Dec 11;11(1):53. doi: 10.1186/s40580-024-00462-1.
7
A novel pan-epitope based nanovaccine self-assembled with CpG enhances immune responses against flavivirus.一种新型的基于泛抗原的纳米疫苗,与 CpG 自组装,增强了对黄病毒的免疫反应。
J Nanobiotechnology. 2024 Nov 28;22(1):738. doi: 10.1186/s12951-024-03031-0.
8
Magnetite nanoparticles: an emerging adjunctive tool for the improvement of cancer immunotherapy.磁铁矿纳米颗粒:一种用于改善癌症免疫治疗的新兴辅助工具。
Explor Target Antitumor Ther. 2024;5(2):316-331. doi: 10.37349/etat.2024.00220. Epub 2024 Apr 23.
9
Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy.肿瘤微环境重塑与癌症免疫治疗中的纳米颗粒。
J Hematol Oncol. 2024 Apr 2;17(1):16. doi: 10.1186/s13045-024-01535-8.
10
Role of Biofunctionalized Nanoparticles in Digestive Cancer Vaccine Development.生物功能化纳米颗粒在消化系统癌症疫苗研发中的作用。
Pharmaceutics. 2024 Mar 16;16(3):410. doi: 10.3390/pharmaceutics16030410.